One-pot synthesis, anticancer, EGFR and caspases assays of novel fused [1,2,3]triazolo-pyrrolo[2,1-b]quinazolinones

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Antoine Daina, Olivier Michielin, Vincent Zoete · Scientific Reports · 2017 · 17.1K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacokinetics +16

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 577 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets

Martin H. Cohen, John R. Johnson, Yeh‐Fong Chen et al. · The Oncologist · 2005 · 441 citations

Medicine, Oncology, Pharmacology +14

Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain

Jin H. Park, Yingting Liu, Mark A. Lemmon et al. · Biochemical Journal · 2012 · 403 citations · Full text

Medicine, Oncology, Pharmacology +17

Promise and challenges in drug discovery and development of hybrid anticancer drugs

Lalji K. Gediya, Vincent C.O. Njar · Expert Opinion on Drug Discovery · 2009 · 220 citations

Pharmacy, Oncology, Pharmacology +15